Methylprednisolone Shows No Clear Benefit for FA Patients in Pilot Trial – Friedreich’s Ataxia News

Treatment with methylprednisolone, an anti-inflammatory medication, had no evident benefit in children and adults with Friedreich’s ataxia (FA) enrolled in a pilot clinical trial conducted at the Children’s Hospital of Philadelphia (CHOP).

Read more at: https://friedreichsataxianews.com/2019/06/20/methylprednisolone-shows-no-clear-benefit-for-fa-patients-in-pilot-trial/

Share
Font Resize